Viewing Study NCT06239467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-05-17 @ 2:45 PM
Study NCT ID: NCT06239467
Status: RECRUITING
Last Update Posted: 2025-09-09
First Post: 2024-01-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
Sponsor: OnKure, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Breast Cancer View
None Advanced Solid Tumors View
None PI3K Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PI3K View
None Solid Tumor View
None Breast Cancer View
None OKI-219 View
None trastuzumab View
None fulvestrant View
None H1047r View
None ribociclib View
None atirmociclib View
None tucatinib View